Cover Image
Market Research Report

Cervical Cancer Test Market & Screening Population Analysis, By Screening Type (Pap Smear, HPV DNA, VIA) - Global Forecast to 2022

Published by iGate Research Pvt Ltd Product code 531804
Published Content info 306 Pages
Immediate Delivery Available
Price
Back to Top
Cervical Cancer Test Market & Screening Population Analysis, By Screening Type (Pap Smear, HPV DNA, VIA) - Global Forecast to 2022
Published: July 24, 2017 Content info: 306 Pages
Description

Cervical cancer is one of the most prevalent forms of cancer affecting women all over the world. In most cases, the disease is attributed to genital Human Papilloma Virus (HPV) infection. As cervical cancer is a disease with long latent period, early detection and treatment of precancerous lesions is known to be highly effective in women who regularly participate in screening programs. The death rate due to cervical cancer has dropped in many developed countries, thus indicating the growing adoption of screening procedures, such as Pap test and HPV testing.

The cervical cancer test market is driven by growth in aging female population and rising prevalence rate of cervical cancer, high incidence rate of HPV infections, rising incidences of teenage sexual cases, increasing number of awareness programs for cervical cancer screening, introduction of low cost VIA test and government initiatives and funding. However, lack of healthcare infrastructure and awareness regarding cervical cancer screening are the major restraints for cervical cancer testing market.

Key Highlights of the Report

  • Cervical cancer is amongst one of the most common causes of deaths in the U.S. women. United States alone captured over 40 percent share of the global cervical cancer test market.
  • Pap test held a majority share of the cervical cancer screening market on account of the high efficiency of this test, however, HPV test is steadily gaining prominence.
  • VIA is the best screening option where access to Pap smear tests and HPV test is not available.
  • In 2016, Global cervical cancer test population was estimated at XXX Million.
  • Cervical cancer incidence rate in Europe is estimated at 10.6 per 100,000 women population.
  • Asia Pacific and North American region are competing closely with each other to grab maximum share of the cervical cancer test population.
  • Indonesia, China, India and Japan captures highest share of the Asian cervical cancer test population.
  • North America captures highest share of the global cervical cancer test market followed by the European region.
  • Germany, United Kingdom and France are the other top three leaders in cervical cancer test market.
  • China and India are the top contributor to the VIA test market.
  • Australia's National Cervical Cancer Screening Program will change from December 2017.

iGATE RESEARCH report titled "Cervical Cancer Test Market & Screening Population Analysis, By Screening Type (Pap Smear, HPV DNA, VIA) - Global Forecast to 2022" is a 306 Page report with 238 Figures and 25 Tables. This report provides a comprehensive assessment of the Cervical Cancer Test (Pap Smear, HPV DNA Test and VIA) Screening Market in terms of Value and Volume terms.

The 20 Countries covered in the report have been analyzed from 4 View Points:

  • 1. Cervical Cancer Test Population (2007 - 2022)
    • Pap Smear Test Population (2007 - 2022)
    • HPV DNA Test population (2007 - 2022)
    • VIA Test Population (2007 - 2022)
  • 2. Cervical Cancer Mortality
  • 3. Cervical Cancer Test Market (2007 - 2022)
    • Pap Smear Test Market (2007 - 2022)
    • HPV DNA Test Market (2007 - 2022)
    • VIA Test Market (2007 - 2022)
  • 4. Global Cervical Cancer Test Market - Driving Factors and Challenges

Cervical Cancer Test Market & Screening Population Analysis - 20 Countries Covered

  • 1. United States
  • 2. Canada
  • 3. United Kingdom
  • 4. France
  • 5. Germany
  • 6. Italy
  • 7. Spain
  • 8. Sweden
  • 9. Switzerland
  • 10. Norway
  • 11. Netherlands
  • 12. Japan
  • 13. South Korea
  • 14. Singapore
  • 15. Malaysia
  • 16. Australia
  • 17. India
  • 18. China
  • 19. Thailand
  • 20. Indonesia

Data Sources

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Table of Contents

Table of Contents

1. Executive Summary

2. Global Cervical Cancer Test (Screening) Population & Forecast (2007 - 2022)

  • 2.1 By Region - Cervical Cancer Test (Screening) Population & Forecast
    • 2.1.1 North America Cervical Cancer Test (Screening) Population & Forecast
    • 2.1.2 Europe Cervical Cancer Test (Screening) Population & Forecast
    • 2.1.3 Asia Pacific Cervical Cancer Test (Screening) Population & Forecast

3. Global Cervical Cancer Test (Screening) Market & Forecast (2007 - 2022)

  • 3.1 By Region - Cervical Cancer Test (Screening) Market & Forecast
    • 3.1.1 North America Cervical Cancer Test (Screening) Market & Forecast
    • 3.1.2 Europe Cervical Cancer Test (Screening) Market & Forecast
    • 3.1.3 Asia Pacific Cervical Cancer Test (Screening) Market & Forecast

4. Global Cervical Cancer Test (Screening) Market & Forecast (2007 - 2022) - By Segment

  • 4.1 Global Cervical Cancer Pap Smear Test (Screening) Market & Forecast
  • 4.2 Global Cervical Cancer HPV DNA Test (Screening) Market & Forecast
  • 4.3 Global Cervical Cancer Visual Inspection with Acetic Acid (VIA) Test (Screening) Market & Forecast

5. Cervical Cancer Test (Screening) Population Share & Forecast (2007 - 2022)

  • 5.1 Global Cervical Cancer Test (Screening) Population Share & Forecast - Regional Analysis
  • 5.2 Global Cervical Cancer Test (Screening) Population Share & Forecast - Country Wise Analysis

6. Global Cervical Cancer Test (Screening) Market Share & Forecast (2007 - 2022)

  • 6.1 Global Cervical Cancer Test (Screening) Market Share & Forecast - Regional Analysis
  • 6.2 Global Cervical Cancer Test (Screening) Market Share & Forecast - Country Wise Analysis
  • 6.3 Global Pap Smear Test (Screening) Market Share & Forecast - Country Wise Analysis
  • 6.4 Global HPV DNA Test (Screening) Market Share & Forecast - Country Wise Analysis
  • 6.5 Global VIA Test (Screening) Market Share & Forecast - Country Wise Analysis
  • 6.6 By Region - Cervical Cancer Test (Screening) Market & Forecast
    • 6.6.1 North America Cervical Cancer Test (Screening) Market Share & Forecast - Country Wise Analysis
    • 6.6.2 Europe Cervical Cancer Test (Screening) Market Share & Forecast - Country Wise Analysis
    • 6.6.3 Asia Pacific Cervical Cancer Test (Screening) Market Share & Forecast - Country Wise Analysis

7. United States - Cervical Cancer Test (Screening) Population and Market Analysis (2007 - 2022)

  • 7.1 United States Cervical Cancer Test (Screening) Population and Forecast
    • 7.1.1 United States Cervical Cancer Pap Smear Test Population & Forecast
    • 7.1.2 United States Cervical Cancer HPV DNA Test Population & Forecast
  • 7.2 United States Cervical Cancer Mortality
  • 7.3 United States Cervical Cancer Test (Screening) Market and Forecast
    • 7.3.1 United States Cervical Cancer Pap Smear Test Market & Forecast
    • 7.3.2 United States Cervical Cancer HPV DNA Test Market & Forecast

8. Canada - Cervical Cancer Test (Screening) Population and Market Analysis (2007 - 2022)

  • 8.1 Canada Cervical Cancer Test (Screening) Population and Forecast
    • 8.1.1 Canada Cervical Cancer Pap Smear Test Population & Forecast
    • 8.1.2 Canada Cervical Cancer HPV DNA Test Population & Forecast
  • 8.2 Canada Cervical Cancer Mortality
  • 8.3 Canada Cervical Cancer Test (Screening) Market and Forecast
    • 8.3.1 Canada Cervical Cancer Pap Smear Test Market & Forecast
    • 8.3.2 Canada Cervical Cancer HPV DNA Test Market & Forecast

9. United Kingdom - Cervical Cancer Test (Screening) Population and Market Analysis (2007 - 2022)

  • 9.1 United Kingdom Cervical Cancer Test (Screening) Population and Forecast
    • 9.1.1 United Kingdom Cervical Cancer Pap Smear Test Population & Forecast
    • 9.1.2 United Kingdom Cervical Cancer HPV DNA Test Population & Forecast
  • 9.2 United Kingdom Cervical Cancer Mortality
  • 9.3 United Kingdom Cervical Cancer Test (Screening) Market and Forecast
    • 9.3.1 United Kingdom Cervical Cancer Pap Smear Test Market & Forecast
    • 9.3.2 United Kingdom Cervical Cancer HPV DNA Test Market & Forecast

10. France - Cervical Cancer Test (Screening) Population and Market Analysis (2007 - 2022)

  • 10.1 France Cervical Cancer Test (Screening) Population and Forecast
    • 10.1.1 France Cervical Cancer Pap Smear Test Population & Forecast
    • 10.1.2 France Cervical Cancer HPV DNA Test Population & Forecast
  • 10.2 France Cervical Cancer Test (Screening) Market and Forecast
    • 10.2.1 France Cervical Cancer Pap Smear Test Market & Forecast
    • 10.2.2 France Cervical Cancer HPV DNA Test Market & Forecast

11. Germany - Cervical Cancer Test (Screening) Population and Market Analysis (2007 - 2022)

  • 11.1 Germany Cervical Cancer Test (Screening) Population and Forecast
    • 11.1.1 Germany Cervical Cancer Pap Smear Test Population & Forecast
    • 11.1.2 Germany Cervical Cancer HPV DNA Test Population & Forecast
  • 11.2 Germany Cervical Cancer Test (Screening) Market and Forecast
    • 11.2.1 Germany Cervical Cancer Pap Smear Test Market & Forecast
    • 11.2.2 Germany Cervical Cancer HPV DNA Test Market & Forecast

12. Italy - Cervical Cancer Test (Screening) Population and Market Analysis (2007 - 2022)

  • 12.1 Italy Cervical Cancer Test (Screening) Population and Forecast
    • 12.1.1 Italy Cervical Cancer Pap Smear Test Population & Forecast
    • 12.1.2 Italy Cervical Cancer HPV DNA Test Population & Forecast
  • 12.2 Italy Cervical Cancer Test (Screening) Market and Forecast
    • 12.2.1 Italy Cervical Cancer Pap Smear Test Market & Forecast
    • 12.2.2 Italy Cervical Cancer HPV DNA Test Market & Forecast

13. Spain - Cervical Cancer Test (Screening) Population and Market Analysis (2007 - 2022)

  • 13.1 Spain Cervical Cancer Test (Screening) Population and Forecast
    • 13.1.1 Spain Cervical Cancer Pap Smear Test Population & Forecast
    • 13.1.2 Spain Cervical Cancer HPV DNA Test Population & Forecast
  • 13.2 Spain Cervical Cancer Test (Screening) Market and Forecast
    • 13.2.1 Spain Cervical Cancer Pap Smear Test Market & Forecast
    • 13.2.2 Spain Cervical Cancer HPV DNA Test Market & Forecast

14. Sweden - Cervical Cancer Test (Screening) Population and Market Analysis (2007 - 2022)

  • 14.1 Sweden Cervical Cancer Test (Screening) Population and Forecast
    • 14.1.1 Sweden Cervical Cancer Pap Smear Test Population & Forecast
    • 14.1.2 Sweden Cervical Cancer HPV DNA Test Population & Forecast
  • 14.2 Sweden Cervical Cancer Test (Screening) Market and Forecast
    • 14.2.1 Sweden Cervical Cancer Pap Smear Test Market & Forecast
    • 14.2.2 Sweden Cervical Cancer HPV DNA Test Market & Forecast

15. Switzerland - Cervical Cancer Test (Screening) Population and Market Analysis (2007 - 2022)

  • 15.1 Switzerland Cervical Cancer Test (Screening) Population and Forecast
    • 15.1.1 Switzerland Cervical Cancer Pap Smear Test Population & Forecast
    • 15.1.2 Switzerland Cervical Cancer HPV DNA Test Population & Forecast
  • 15.2 Switzerland Cervical Cancer Test (Screening) Market and Forecast
    • 15.2.1 Switzerland Cervical Cancer Pap Smear Test Market & Forecast
    • 15.2.2 Switzerland Cervical Cancer HPV DNA Test Market & Forecast

16. Norway - Cervical Cancer Test (Screening) Population and Market Analysis (2007 - 2022)

  • 16.1 Norway Cervical Cancer Test (Screening) Population and Forecast
    • 16.1.1 Norway Cervical Cancer Pap Smear Test Population & Forecast
    • 16.1.2 Norway Cervical Cancer HPV DNA Test Population & Forecast
  • 16.2 Norway Cervical Cancer Test (Screening) Market and Forecast
    • 16.2.1 Norway Cervical Cancer Pap Smear Test Market & Forecast
    • 16.2.2 Norway Cervical Cancer HPV DNA Test Market & Forecast

17. Netherlands - Cervical Cancer Test (Screening) Population and Market Analysis (2007 - 2022)

  • 17.1 Netherlands Cervical Cancer Test (Screening) Population and Forecast
    • 17.1.1 Netherlands Cervical Cancer Pap Smear Test Population & Forecast
    • 17.1.2 Netherlands Cervical Cancer HPV DNA Test Population & Forecast
  • 17.2 Netherlands Cervical Cancer Test (Screening) Market and Forecast
    • 17.2.1 Netherlands Cervical Cancer Pap Smear Test Market & Forecast
    • 17.2.2 Netherlands Cervical Cancer HPV DNA Test Market & Forecast

18. Japan - Cervical Cancer Test (Screening) Population and Market Analysis (2007 - 2022)

  • 18.1 Japan Cervical Cancer Test (Screening) Population and Forecast
    • 18.1.1 Japan Cervical Cancer Pap Smear Test Population & Forecast
    • 18.1.2 Japan Cervical Cancer HPV DNA Test Population & Forecast
  • 18.2 Japan Cervical Cancer Test (Screening) Market and Forecast
    • 18.2.1 Japan Cervical Cancer Pap Smear Test Market & Forecast
    • 18.2.2 Japan Cervical Cancer HPV DNA Test Market & Forecast

19. South Korea - Cervical Cancer Test (Screening) Population and Market Analysis (2007 - 2022)

  • 19.1 South Korea Cervical Cancer Test (Screening) Population and Forecast
    • 19.1.1 South Korea Cervical Cancer Pap Smear Test Population & Forecast
    • 19.1.2 South Korea Cervical Cancer HPV DNA Test Population & Forecast
    • 19.2 South Korea Cervical Cancer Mortality
  • 19.3 South Korea Cervical Cancer Test (Screening) Market and Forecast
    • 19.3.1 South Korea Cervical Cancer Pap Smear Test Market & Forecast
    • 19.3.2 South Korea Cervical Cancer HPV DNA Test Market & Forecast

20. Singapore - Cervical Cancer Test (Screening) Population and Market Analysis (2007 - 2022)

  • 20.1 Singapore Cervical Cancer Test (Screening) Population and Forecast
    • 20.1.1 Singapore Cervical Cancer Pap Smear Test Population & Forecast
    • 20.1.2 Singapore Cervical Cancer HPV DNA Test Population & Forecast
  • 20.2 Singapore Cervical Cancer Test (Screening) Market and Forecast
    • 20.2.1 Singapore Cervical Cancer Pap Smear Test Market & Forecast
    • 20.2.2 Singapore Cervical Cancer HPV DNA Test Market & Forecast

21. Malaysia - Cervical Cancer Test (Screening) Population and Market Analysis (2007 - 2022)

  • 21.1 Malaysia Cervical Cancer Test (Screening) Population and Forecast
    • 21.1.1 Malaysia Cervical Cancer Pap Smear Test Population & Forecast
    • 21.1.2 Malaysia Cervical Cancer HPV DNA Test Population & Forecast
  • 21.2 Malaysia Cervical Cancer Test (Screening) Market and Forecast
    • 21.2.1 Malaysia Cervical Cancer Pap Smear Test Market & Forecast
    • 21.2.2 Malaysia Cervical Cancer HPV DNA Test Market & Forecast

22. India - Cervical Cancer Test (Screening) Population and Market Analysis (2007 - 2022)

  • 22.1 India Cervical Cancer Test (Screening) Population and Forecast
    • 22.1.1 India Cervical Cancer Pap Smear Test Population & Forecast
    • 22.1.2 India Cervical Cancer HPV DNA Test Population & Forecast
    • 22.1.3 India Cervical Cancer VIA Test Population & Forecast
  • 22.2 India Cervical Cancer Test (Screening) Market and Forecast
    • 22.2.1 India Cervical Cancer Pap Smear Test Market & Forecast
    • 22.2.2 India Cervical Cancer HPV DNA Test Market & Forecast
    • 22.2.3 India Cervical Cancer VIA Test Market & Forecast

23. China - Cervical Cancer Test (Screening) Population and Market Analysis (2007 - 2022)

  • 23.1 China Cervical Cancer Test (Screening) Population and Forecast
    • 23.1.1 China Cervical Cancer Pap Smear Test Population & Forecast
    • 23.1.2 China Cervical Cancer HPV DNA Test Population & Forecast
    • 23.1.3 China Cervical Cancer VIA Test Population & Forecast
  • 23.2 China Cervical Cancer Test (Screening) Market and Forecast
    • 23.2.1 China Cervical Cancer Pap Smear Test Market & Forecast
    • 23.2.2 China Cervical Cancer HPV DNA Test Market & Forecast
    • 23.2.3 China Cervical Cancer VIA Test Market & Forecast

24. Thailand - Cervical Cancer Test (Screening) Population and Market Analysis (2007 - 2022)

  • 24.1 Thailand Cervical Cancer Test (Screening) Population and Forecast
    • 24.1.1 Thailand Cervical Cancer Pap Smear Test Population & Forecast
    • 24.1.2 Thailand Cervical Cancer VIA Test Population & Forecast
  • 24.2 Thailand Cervical Cancer Test (Screening) Market and Forecast
    • 24.2.1 Thailand Cervical Cancer Pap Smear Test Market & Forecast
    • 24.2.2 Thailand Cervical Cancer VIA Test Market & Forecast

25. Indonesia - Cervical Cancer Test (Screening) Population and Market Analysis (2007 - 2022)

  • 25.1 Indonesia Cervical Cancer Test (Screening) Population and Forecast
    • 25.1.1 Indonesia Cervical Cancer Pap Smear Test Population & Forecast
    • 25.1.2 Indonesia Cervical Cancer HPV DNA Test Population & Forecast
    • 25.1.3 Indonesia Cervical Cancer VIA Test Population & Forecast
    • 25.1.4 Indonesia Cervical Cancer Both (Pap Smear & VIA) Test Population & Forecast
  • 25.2 Indonesia Cervical Cancer Test (Screening) Market and Forecast
    • 25.2.1 Indonesia Cervical Cancer Pap Smear Test Market & Forecast
    • 25.2.2 Indonesia Cervical Cancer HPV DNA Test Market & Forecast
    • 25.2.3 Indonesia Cervical Cancer VIA Test Market & Forecast
    • 25.2.4 Indonesia Cervical Cancer Both (Pap Smear & VIA) Test Market & Forecast

26. Australia - Cervical Cancer Test (Screening) Population and Market Analysis (2007 - 2017)

  • 26.1 Australia Cervical Cancer Test (Screening) Population and Forecast
    • 26.1.1 Australia Cervical Cancer Pap Smear Test Population & Forecast
    • 26.1.2 Australia Cervical Cancer HPV DNA Test Population & Forecast
  • 26.2 Australia Cervical Cancer Mortality
  • 26.3 Australia Cervical Cancer Test (Screening) Market and Forecast
    • 26.3.1 Australia Cervical Cancer Pap Smear Test Market & Forecast
    • 26.3.2 Australia Cervical Cancer HPV DNA Test Market & Forecast

27. Cervical Cancer Test (Screening) Market - Driving Factors

  • 27.1 Introduction of Low Cost VIA Test
    • 27.1.1 Countries Offering VIA Test via National Programs
    • 27.1.2 Countries Offering VIA Test via Pilot Programs
  • 27.2 High Prevalence of HPV Infected Patients Globally
  • 27.3 Rising Incidence of Teenage Sexual Cases Globally

28. Cervical Cancer Test (Screening) Market - Challenges

  • 28.1 Lack of Appropriate Healthcare Infrastructure
  • 28.2 Introduction of HPV Vaccination Programs Worldwide

List of Figures:

  • Figure 2-1: Global - Cervical Cancer Test Population (Million), 2007 - 2016
  • Figure 2-2: Global - Forecast for Cervical Cancer Test Population (Million), 2017 - 2022
  • Figure 2-3: North America - Cervical Cancer Test Population (Million), 2007 - 2016
  • Figure 2-4: North America - Forecast for Cervical Cancer Test Population (Million), 2017 - 2022
  • Figure 2-5: Europe - Cervical Cancer Test Population (Million), 2007 - 2016
  • Figure 2-6: Europe - Forecast for Cervical Cancer Test Population (Million), 2017 - 2022
  • Figure 2-7: Asia Pacific - Cervical Cancer Test Population (Million), 2007 - 2016
  • Figure 2-8: Asia Pacific - Forecast for Cervical Cancer Test Population (Million), 2017 - 2022
  • Figure 3-1: Global - Cervical Cancer Test Market (Million US$), 2007 - 2016
  • Figure 3-2: Global - Forecast for Cervical Cancer Test Market (Million US$), 2017 - 2022
  • Figure 3-3: North America - Cervical Cancer Test Market (Million US$), 2007 - 2016
  • Figure 3-4: North America - Forecast for Cervical Cancer Test Market (Million US$), 2017 - 2022
  • Figure 3-5: Europe - Cervical Cancer Test Market (Million US$), 2007 - 2016
  • Figure 3-6: Europe - Forecast for Cervical Cancer Test Market (Million US$), 2017 - 2022
  • Figure 3-7: Asia Pacific - Cervical Cancer Test Market (Million US$), 2007 - 2016
  • Figure 3-8: Asia Pacific - Forecast for Cervical Cancer Test Market (Million US$), 2017 - 2022
  • Figure 4-1: Global - Cervical Cancer Pap Smear Test Market (Million US$), 2007 - 2016
  • Figure 4-2: Global - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2017 - 2022
  • Figure 4-3: Global - Cervical Cancer HPV DNA Test Market (Million US$), 2007 - 2016
  • Figure 4-4: Global - Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2017 - 2022
  • Figure 4-5: Global - Cervical Cancer VIA Test Market (Million US$), 2007 - 2016
  • Figure 4-6: Global - Forecast for Cervical Cancer VIA Test Market (Million US$), 2017 - 2022
  • Figure 7-1: United States - Cervical Cancer Pap Smear Test Population (Thousand), 2007 - 2016
  • Figure 7-2: United States - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2017 - 2022
  • Figure 7-3: United States - Cervical Cancer HPV DNA Test Population (Thousand), 2007 - 2016
  • Figure 7-4: United States - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2017 - 2022
  • Figure 7-5: United States - Cervical Cancer Mortality (Number), 2010 - 2017
  • Figure 7-6: United States - Cervical Cancer Test Market (Million US$), 2007 - 2016
  • Figure 7-7: United States - Forecast for Cervical Cancer Test Market (Million US$), 2017 - 2022
  • Figure 7-8: United States - Cervical Cancer Pap Smear Test Market (Million US$), 2007 - 2016
  • Figure 7-9: United States - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2017 - 2022
  • Figure 7-10: United States - Cervical Cancer HPV DNA Test Market (Million US$), 2007 - 2016
  • Figure 7-11: United States - Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2017 - 2022
  • Figure 8-1: Canada - Cervical Cancer Pap Smear Test Population (Thousand), 2007 - 2016
  • Figure 8-2: Canada - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2017 - 2022
  • Figure 8-3: Canada - Cervical Cancer HPV DNA Test Population (Thousand), 2007 - 2016
  • Figure 8-4: Canada - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2017 - 2022
  • Figure 8-5: Canada - Cervical Cancer Mortality (Number), 2010 - 2017
  • Figure 8-6: Canada - Cervical Cancer Test Market (Million US$), 2007 - 2016
  • Figure 8-7: Canada - Forecast for Cervical Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-8: Canada - Cervical Cancer Pap Smear Test Market (Million US$), 2007 - 2016
  • Figure 8-9: Canada - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2017 - 2022
  • Figure 8-10: Canada - Cervical Cancer HPV DNA Test Market (Million US$), 2007 - 2016
  • Figure 8-11: Canada - Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2017 - 2022
  • Figure 9-1: United Kingdom - Cervical Cancer Pap Smear Test Population (Thousand), 2007 - 2016
  • Figure 9-2: United Kingdom - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2017 - 2022
  • Figure 9-3: United Kingdom - Cervical Cancer HPV DNA Test Population (Thousand), 2007 - 2016
  • Figure 9-4: United Kingdom - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2017 - 2022
  • Figure 9-5: United Kingdom - Cervical Cancer Mortality (Number), 2001 - 2014
  • Figure 9-6: United Kingdom - Cervical Cancer Test Market (Million US$), 2007 - 2016
  • Figure 9-7: United Kingdom - Forecast for Cervical Cancer Test Market (Million US$), 2017 - 2022
  • Figure 9-8: United Kingdom - Cervical Cancer Pap Smear Test Market (Million US$), 2007 - 2016
  • Figure 9-9: United Kingdom - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2017 - 2022
  • Figure 9-10: United Kingdom - Cervical Cancer HPV DNA Test Market (Million US$), 2007 - 2016
  • Figure 9-11: United Kingdom - Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2017 - 2022
  • Figure 10-1: France - Cervical Cancer Pap Smear Test Population (Thousand), 2007 - 2016
  • Figure 10-2: France - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2017 - 2022
  • Figure 10-3: France - Cervical Cancer HPV DNA Test Population (Thousand), 2007 - 2016
  • Figure 10-4: France - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2017 - 2022
  • Figure 10-5: France - Cervical Cancer Test Market (Million US$), 2007 - 2016
  • Figure 10-6: France - Forecast for Cervical Cancer Test Market (Million US$), 2017 - 2022
  • Figure 10-7: France - Cervical Cancer Pap Smear Test Market (Million US$), 2007 - 2016
  • Figure 10-8: France - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2017 - 2022
  • Figure 10-9: France - Cervical Cancer HPV DNA Test Market (Million US$), 2007 - 2016
  • Figure 10-10: France - Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2017 - 2022
  • Figure 11-1: Germany - Cervical Cancer Pap Smear Test Population (Thousand), 2007 - 2016
  • Figure 11-2: Germany - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2017 - 2022
  • Figure 11-3: Germany - Cervical Cancer HPV DNA Test Population (Thousand), 2007 - 2016
  • Figure 11-4: Germany - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2017 - 2022
  • Figure 11-5: Germany - Cervical Cancer Test Market (Million US$), 2007 - 2016
  • Figure 11-6: Germany - Forecast for Cervical Cancer Test Market (Million US$), 2017 - 2022
  • Figure 11-7: Germany - Cervical Cancer Pap Smear Test Market (Million US$), 2007 - 2016
  • Figure 11-8: Germany - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2017 - 2022
  • Figure 11-9: Germany - Cervical Cancer HPV DNA Test Market (Million US$), 2007 - 2016
  • Figure 11-10: Germany - Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2017 - 2022
  • Figure 12-1: Italy - Cervical Cancer Pap Smear Test Population (Thousand), 2007 - 2016
  • Figure 12-2: Italy - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2017 - 2022
  • Figure 12-3: Italy - Cervical Cancer HPV DNA Test Population (Thousand), 2007 - 2016
  • Figure 12-4: Italy - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2017 - 2022
  • Figure 12-5: Italy - Cervical Cancer Test Market (Million US$), 2007 - 2016
  • Figure 12-6: Italy - Forecast for Cervical Cancer Test Market (Million US$), 2017 - 2022
  • Figure 12-7: Italy - Cervical Cancer Pap Smear Test Market (Million US$), 2007 - 2016
  • Figure 12-8: Italy - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2017 - 2022
  • Figure 12-9: Italy - Cervical Cancer HPV DNA Test Market (Million US$), 2007 - 2016
  • Figure 12-10: Italy - Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2017 - 2022
  • Figure 13-1: Spain - Cervical Cancer Pap Smear Test Population (Thousand), 2007 - 2016
  • Figure 13-2: Spain - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2017 - 2022
  • Figure 13-3: Spain - Cervical Cancer HPV DNA Test Population (Thousand), 2007 - 2016
  • Figure 13-4: Spain - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2017 - 2022
  • Figure 13-5: Spain - Cervical Cancer Test Market (Million US$), 2007 - 2016
  • Figure 13-6: Spain - Forecast for Cervical Cancer Test Market (Million US$), 2017 - 2022
  • Figure 13-7: Spain - Cervical Cancer Pap Smear Test Market (Million US$), 2007 - 2016
  • Figure 13-8: Spain - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2017 - 2022
  • Figure 13-9: Spain - Cervical Cancer HPV DNA Test Market (Million US$), 2007 - 2016
  • Figure 13-10: Spain - Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2017 - 2022
  • Figure 14-1: Sweden - Cervical Cancer Pap Smear Test Population (Thousand), 2007 - 2016
  • Figure 14-2: Sweden - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2017 - 2022
  • Figure 14-3: Sweden - Cervical Cancer HPV DNA Test Population (Thousand), 2007 - 2016
  • Figure 14-4: Sweden - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2017 - 2022
  • Figure 14-5: Sweden - Cervical Cancer Test Market (Million US$), 2007 - 2016
  • Figure 14-6: Sweden - Forecast for Cervical Cancer Test Market (Million US$), 2017 - 2022
  • Figure 14-7: Sweden - Cervical Cancer Pap Smear Test Market (Million US$), 2007 - 2016
  • Figure 14-8: Sweden - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2017 - 2022
  • Figure 14-9: Sweden - Cervical Cancer HPV DNA Test Market (Million US$), 2007 - 2016
  • Figure 14-10: Sweden - Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2017 - 2022
  • Figure 15-1: Switzerland - Cervical Cancer Pap Smear Test Population (Thousand), 2007 - 2016
  • Figure 15-2: Switzerland - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2017 - 2022
  • Figure 15-3: Switzerland - Cervical Cancer HPV DNA Test Population (Thousand), 2007 - 2016
  • Figure 15-4: Switzerland - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2017 - 2022
  • Figure 15-5: Switzerland - Cervical Cancer Test Market (Million US$), 2007 - 2016
  • Figure 15-6: Switzerland - Forecast for Cervical Cancer Test Market (Million US$), 2017 - 2022
  • Figure 15-7: Switzerland - Cervical Cancer Pap Smear Test Market (Million US$), 2007 - 2016
  • Figure 15-8: Switzerland - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2017 - 2022
  • Figure 15-9: Switzerland - Cervical Cancer HPV DNA Test Market (Million US$), 2007 - 2016
  • Figure 15-10: Switzerland - Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2017 - 2022
  • Figure 16-1: Norway - Cervical Cancer Pap Smear Test Population (Thousand), 2007 - 2016
  • Figure 16-2: Norway - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2017 - 2022
  • Figure 16-3: Norway - Cervical Cancer HPV DNA Test Population (Thousand), 2007 - 2016
  • Figure 16-4: Norway - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2017 - 2022
  • Figure 16-5: Norway - Cervical Cancer Test Market (Million US$), 2007 - 2016
  • Figure 16-6: Norway - Forecast for Cervical Cancer Test Market (Million US$), 2017 - 2022
  • Figure 16-7: Norway - Cervical Cancer Pap Smear Test Market (Million US$), 2007 - 2016
  • Figure 16-8: Norway - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2017 - 2022
  • Figure 16-9: Norway - Cervical Cancer HPV DNA Test Market (Million US$), 2007 - 2016
  • Figure 16-10: Norway - Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2017 - 2022
  • Figure 17-1: Netherlands - Cervical Cancer Pap Smear Test Population (Thousand), 2007 - 2016
  • Figure 17-2: Netherlands - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2017 - 2022
  • Figure 17-3: Netherlands - Cervical Cancer HPV DNA Test Population (Thousand), 2007 - 2016
  • Figure 17-4: Netherlands - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2017 - 2022
  • Figure 17-5: Netherlands - Cervical Cancer Test Market (Million US$), 2007 - 2016
  • Figure 17-6: Netherlands - Forecast for Cervical Cancer Test Market (Million US$), 2017 - 2022
  • Figure 17-7: Netherlands - Cervical Cancer Pap Smear Test Market (Million US$), 2007 - 2016
  • Figure 17-8: Netherlands - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2017 - 2022
  • Figure 17-9: Netherlands - Cervical Cancer HPV DNA Test Market (Million US$), 2007 - 2016
  • Figure 17-10: Netherlands - Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2017 - 2022
  • Figure 18-1: Japan - Cervical Cancer Pap Smear Test Population (Thousand), 2007 - 2016
  • Figure 18-2: Japan - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2017 - 2022
  • Figure 18-3: Japan - Cervical Cancer HPV DNA Test Population (Thousand), 2007 - 2016
  • Figure 18-4: Japan - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2017 - 2022
  • Figure 18-5: Japan - Cervical Cancer Test Market (Million US$), 2007 - 2016
  • Figure 18-6: Japan - Forecast for Cervical Cancer Test Market (Million US$), 2017 - 2022
  • Figure 18-7: Japan - Cervical Cancer Pap Smear Test Market (Million US$), 2007 - 2016
  • Figure 18-8: Japan - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2017 - 2022
  • Figure 18-9: Japan - Cervical Cancer HPV DNA Test Market (Million US$), 2007 - 2016
  • Figure 18-10: Japan - Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2017 - 2022
  • Figure 19-1: South Korea - Cervical Cancer Pap Smear Test Population (Thousand), 2007 - 2016
  • Figure 19-2: South Korea - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2017 - 2022
  • Figure 19-3: South Korea - Cervical Cancer HPV DNA Test Population (Thousand), 2007 - 2016
  • Figure 19-4: South Korea - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2017 - 2022
  • Figure 19-5: South Korea - Cervical Cancer Mortality (Number), 2009 - 2013
  • Figure 19-6: South Korea - Cervical Cancer Test Market (Million US$), 2007 - 2016
  • Figure 19-7: South Korea - Forecast for Cervical Cancer Test Market (Million US$), 2017 - 2022
  • Figure 19-8: South Korea - Cervical Cancer Pap Smear Test Market (Million US$), 2007 - 2016
  • Figure 19-9: South Korea - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2017 - 2022
  • Figure 19-10: South Korea - Cervical Cancer HPV DNA Test Market (Million US$), 2007 - 2016
  • Figure 19-11: South Korea - Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2017 - 2022
  • Figure 20-1: Singapore - Cervical Cancer Pap Smear Test Population (Thousand), 2007 - 2016
  • Figure 20-2: Singapore - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2017 - 2022
  • Figure 20-3: Singapore - Cervical Cancer HPV DNA Test Population (Thousand), 2007 - 2016
  • Figure 20-4: Singapore - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2017 - 2022
  • Figure 20-5: Singapore - Cervical Cancer Test Market (Million US$), 2007 - 2016
  • Figure 20-6: Singapore - Forecast for Cervical Cancer Test Market (Million US$), 2017 - 2022
  • Figure 20-7: Singapore - Cervical Cancer Pap Smear Test Market (Million US$), 2007 - 2016
  • Figure 20-8: Singapore - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2017 - 2022
  • Figure 20-9: Singapore - Cervical Cancer HPV DNA Test Market (Million US$), 2007 - 2016
  • Figure 20-10: Singapore - Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2017 - 2022
  • Figure 21-1: Malaysia - Cervical Cancer Pap Smear Test Population (Thousand), 2007 - 2016
  • Figure 21-2: Malaysia - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2017 - 2022
  • Figure 21-3: Malaysia - Cervical Cancer HPV DNA Test Population (Thousand), 2007 - 2016
  • Figure 21-4: Malaysia - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2017 - 2022
  • Figure 21-5: Malaysia - Cervical Cancer Test Market (Million US$), 2007 - 2016
  • Figure 21-6: Malaysia - Forecast for Cervical Cancer Test Market (Million US$), 2017 - 2022
  • Figure 21-7: Malaysia - Cervical Cancer Pap Smear Test Market (Million US$), 2007 - 2016
  • Figure 21-8: Malaysia - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2017 - 2022
  • Figure 21-9: Malaysia - Cervical Cancer HPV DNA Test Market (Million US$), 2007 - 2016
  • Figure 21-10: Malaysia - Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2017 - 2022
  • Figure 22-1: India - Cervical Cancer Pap Smear Test Population (Thousand), 2007 - 2016
  • Figure 22-2: India - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2017 - 2022
  • Figure 22-3: India - Cervical Cancer HPV DNA Test Population (Thousand), 2007 - 2016
  • Figure 22-4: India - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2017 - 2022
  • Figure 22-5: India - Cervical Cancer VIA Test Population (Thousand), 2007 - 2016
  • Figure 22-6: India - Forecast for Cervical Cancer VIA Test Population (Thousand), 2017 - 2022
  • Figure 22-7: India - Cervical Cancer Test Market (Million US$), 2007 - 2016
  • Figure 22-8: India - Forecast for Cervical Cancer Test Market (Million US$), 2017 - 2022
  • Figure 22-9: India - Cervical Cancer Pap Smear Test Market (Million US$), 2007 - 2016
  • Figure 22-10: India - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2017 - 2022
  • Figure 22-11: India - Cervical Cancer HPV DNA Test Market (Million US$), 2007 - 2016
  • Figure 22-12: India - Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2017 - 2022
  • Figure 22-13: India - Cervical Cancer VIA Test Market (Million US$), 2007 - 2016
  • Figure 22-14: India - Forecast for Cervical Cancer VIA Test Market (Million US$), 2017 - 2022
  • Figure 23-1: China - Cervical Cancer Pap Smear Test Population (Thousand), 2007 - 2016
  • Figure 23-2: China - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2017 - 2022
  • Figure 23-3: China - Cervical Cancer HPV DNA Test Population (Thousand), 2007 - 2016
  • Figure 23-4: China - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2017 - 2022
  • Figure 23-5: China - Cervical Cancer VIA Test Population (Thousand), 2007 - 2016
  • Figure 23-6: China - Forecast for Cervical Cancer VIA Test Population (Thousand), 2017 - 2022
  • Figure 23-7: China - Cervical Cancer Test Market (Million US$), 2007 - 2016
  • Figure 23-8: China - Forecast for Cervical Cancer Test Market (Million US$), 2017 - 2022
  • Figure 23-9: China - Cervical Cancer Pap Smear Test Market (Million US$), 2007 - 2016
  • Figure 23-10: China - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2017 - 2022
  • Figure 23-11: China - Cervical Cancer HPV DNA Test Market (Million US$), 2007 - 2016
  • Figure 23-12: China - Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2017 - 2022
  • Figure 23-13: China - Cervical Cancer VIA Test Market (Million US$), 2007 - 2016
  • Figure 23-14: China - Forecast for Cervical Cancer VIA Test Market (Million US$), 2017 - 2022
  • Figure 24-1: Thailand - Cervical Cancer Pap Smear Test Population (Thousand), 2007 - 2016
  • Figure 24-2: Thailand - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2017 - 2022
  • Figure 24-3: Thailand - Cervical Cancer VIA Test Population (Thousand), 2007 - 2016
  • Figure 24-4: Thailand - Forecast for Cervical Cancer VIA Test Population (Thousand), 2017 - 2022
  • Figure 24-5: Thailand - Cervical Cancer Test Market (Million US$), 2007 - 2016
  • Figure 24-6: Thailand - Forecast for Cervical Cancer Test Market (Million US$), 2017 - 2022
  • Figure 24-7: Thailand - Cervical Cancer Pap Smear Test Market (Million US$), 2007 - 2016
  • Figure 24-8: Thailand - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2017 - 2022
  • Figure 24-9: Thailand - Cervical Cancer VIA Test Market (Million US$), 2007 - 2016
  • Figure 24-10: Thailand - Forecast for Cervical Cancer VIA Test Market (Million US$), 2017 - 2022
  • Figure 25-1: Indonesia - Cervical Cancer Pap Smear Test Population (Thousand), 2007 - 2016
  • Figure 25-2: Indonesia - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2017 - 2022
  • Figure 25-3: Indonesia - Cervical Cancer HPV DNA Test Population (Thousand), 2007 - 2016
  • Figure 25-4: Indonesia - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2017 - 2022
  • Figure 25-5: Indonesia - Cervical Cancer VIA Test Population (Thousand), 2007 - 2016
  • Figure 25-6: Indonesia - Forecast for Cervical Cancer VIA Test Population (Thousand), 2017 - 2022
  • Figure 25-7: Indonesia - Cervical Cancer Both (Pap Smear & VIA) Test Population (Thousand), 2007 - 2016
  • Figure 25-8: Indonesia - Forecast for Cervical Cancer Both (Pap Smear & VIA) Test Population (Thousand), 2017 - 2022
  • Figure 25-9: Indonesia - Cervical Cancer Test Market (Million US$), 2007 - 2016
  • Figure 25-10: Indonesia - Forecast for Cervical Cancer Test Market (Million US$), 2017 - 2022
  • Figure 25-11: Indonesia - Cervical Cancer Pap Smear Test Market (Million US$), 2007 - 2016
  • Figure 25-12: Indonesia - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2017 - 2022
  • Figure 25-13: Indonesia - Cervical Cancer HPV DNA Test Market (Million US$), 2007 - 2016
  • Figure 25-14: Indonesia - Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2017 - 2022
  • Figure 25-15: Indonesia - Cervical Cancer VIA Test Market (Million US$), 2007 - 2016
  • Figure 25-16: Indonesia - Forecast for Cervical Cancer VIA Test Market (Million US$), 2017 - 2022
  • Figure 25-17: Indonesia - Cervical Cancer Both (Pap Smear & VIA) Test Market (Million US$), 2007 - 2016
  • Figure 25-18: Indonesia - Forecast for Cervical Cancer Both (Pap Smear & VIA) Test Market (Million US$), 2017 - 2022
  • Figure 26-1: Australia - Cervical Cancer Pap Smear Test Population and Forecast (Thousand), 2007 - 2017
  • Figure 26-2: Australia - Cervical Cancer HPV DNA Test Population and Forecast (Thousand), 2007 - 2017
  • Figure 26-3: Australia - Cervical Cancer Mortality (Number), 2001 - 2017
  • Figure 26-4: Australia - Cervical Cancer Test Market and Forecast (Million US$), 2007 - 2017
  • Figure 26-5: Australia - Cervical Cancer Pap Smear Test Market and Forecast (Million US$), 2007 - 2017
  • Figure 26-6: Australia - Cervical Cancer HPV DNA Test Market and Forecast (Million US$), 2007 - 2017

List of Tables:

  • Table 5-1: By Region - Cervical Cancer Test Population Share (Percent), 2007 - 2016
  • Table 5-2: By Region - Forecast for Cervical Cancer Test Population Share (Percent), 2017 - 2022
  • Table 5-3: Global - Cervical Cancer Test Population Share (Percent), 2007 - 2016
  • Table 5-4: Global - Forecast for Cervical Cancer Test Population Share (Percent), 2017 - 2022
  • Table 6-1: By Region - Cervical Cancer Test Market Share (Percent), 2007 - 2016
  • Table 6-2: By Region - Forecast for Cervical Cancer Test Market Share (Percent), 2017 - 2022
  • Table 6-3: Global - Cervical Cancer Test Market Share (Percent), 2007 - 2016
  • Table 6-4: Global - Forecast for Cervical Cancer Test Market Share (Percent), 2017 - 2022
  • Table 6-5: Global - Cervical Cancer Pap Smear Test Market Share (Percent), 2007 - 2016
  • Table 6-6: Global - Forecast for Cervical Cancer Pap Smear Test Market Share (Percent), 2017 - 2022
  • Table 6-7: Global - Cervical Cancer HPV DNA Test Market Share (Percent), 2007 - 2016
  • Table 6-8: Global - Forecast for Cervical Cancer HPV DNA Test Market Share (Percent), 2017 - 2022
  • Table 6-9: Global - Cervical Cancer VIA Test Market Share (Percent), 2007 - 2016
  • Table 6-10: Global - Forecast for Cervical Cancer VIA Test Market Share (Percent), 2017 - 2022
  • Table 6-11: North America - Cervical Cancer Test Market Share (Percent), 2007 - 2016
  • Table 6-12: North America - Forecast for Cervical Cancer Test Market Share (Percent), 2017 - 2022
  • Table 6-13: Europe - Cervical Cancer Test Market Share (Percent), 2007 - 2016
  • Table 6-14: Europe - Forecast for Cervical Cancer Test Market Share (Percent), 2017 - 2022
  • Table 6-15: Asia Pacific - Cervical Cancer Test Market Share (Percent), 2007 - 2016
  • Table 6-16: Asia Pacific - Forecast for Cervical Cancer Test Market Share (Percent), 2017 - 2022
  • Table 9-1: United Kingdom - HPV Testing by Country
  • Table 27-1: Worldwide - List of Countries which offer VIA Test via National Programs, 2010
  • Table 27-2: Worldwide - List of Countries which offer VIA Test via Pilot Programs, 2010
  • Table 27-3: Worldwide - HPV Prevalence (Percent) among Women with Normal Cervical Cytology, 2010
  • Table 27-4: Worldwide - Prevalence (Percent) of Young Women (15-44 Years) who Have Sex before the Age of 15 Years, 1994 - 2006
Back to Top